Enalapril and Breastfeeding
Yes, you can safely continue breastfeeding while taking enalapril—it is specifically recommended as a first-line ACE inhibitor for lactating mothers due to its favorable safety profile and minimal transfer into breast milk. 1, 2, 3
Why Enalapril is Safe During Breastfeeding
Enalapril is the most widely used and recommended ACE inhibitor for breastfeeding mothers due to its safety and favorable pharmacokinetics 1. The 2025 Circulation guidelines explicitly list enalapril as a safe first-line agent with a relative infant dose (RID) of only 1.1%—well below the 10% safety threshold 2. The 2020 European Heart Journal position paper specifically states that "ACE inhibitors can be used in lactating mothers unless the neonate is premature or has renal failure" and singles out enalapril as particularly suitable 1.
Recent pharmacokinetic data from 2025 confirms extremely low transfer into breast milk: enalapril concentrations ranged from 0.01-1.22 ng/mL and enalaprilat (active metabolite) from 0.32-0.77 ng/mL, with infant plasma levels below detectable limits 4. The calculated RID was only 0.073-0.097%, representing negligible infant exposure 4.
Important Contraindications
Do NOT use enalapril if your infant is:
These are the only absolute contraindications for enalapril during breastfeeding.
Infant Monitoring Recommendations
While enalapril is safe, observe your infant for:
- Hypotension (low blood pressure—infant appears pale, lethargic, or feeds poorly)
- Oliguria (decreased urine output—fewer than 6 wet diapers per day in term infants)
- Hyperkalemia (rare, but watch for muscle weakness or irregular heartbeat)
The FDA label specifically advises monitoring for these signs in infants with in utero exposure, and this prudent approach extends to breastfed infants 5. However, given the minimal milk transfer documented, clinically significant effects are highly unlikely in healthy term infants 4.
Practical Dosing Guidance
- Starting dose: 5 mg daily 2
- Maximum dose: 40 mg daily (or 20 mg twice daily) 2
- Titration interval: Every 5-7 days in stable patients 2
The 2025 guidelines recommend targeting blood pressure ≤140/90 mmHg in clinic (approximately ≤135/85 mmHg at home) 6.
Alternative First-Line Options
If enalapril is not suitable, other lactation-safe first-line antihypertensives include 2, 3:
- Nifedipine extended-release (RID 2.3-3.4%)—may actually reduce readmissions more than labetalol 6
- Amlodipine (RID 1.7-4.3%)
- Labetalol (RID 3.6%)
- Captopril (another ACE inhibitor option) 3
Common Pitfalls to Avoid
Don't confuse pregnancy with lactation safety: While ACE inhibitors are absolutely contraindicated in pregnancy due to fetal toxicity 5, they are safe and recommended during breastfeeding 1, 2, 3
Don't unnecessarily discontinue breastfeeding: The FDA label states "a decision should be made whether to discontinue nursing or discontinue enalapril" 5, but this reflects outdated medicolegal language. Current evidence-based guidelines from multiple prestigious societies (ESC, AHA, Hypertension Canada) explicitly support enalapril use during breastfeeding 1, 2, 3
Avoid diuretics as first-line: Thiazide and loop diuretics may reduce milk production, particularly at higher doses (>25 mg/day for hydrochlorothiazide, >20 mg/day for furosemide) 1, 2
When to Seek Medical Attention
Contact your healthcare provider immediately if your infant shows:
- Excessive sleepiness or difficulty waking for feeds
- Poor feeding or refusal to feed
- Significantly fewer wet diapers than usual
- Unusual paleness or lethargy